Personalised treatment funding in European Union (EU-wide)

Personalised treatment funding calls and grant programmes in European Union (EU-wide), collected from the official EU and national registers. 6 calls on record, 1 currently open.

Latest calls

• Advancing bio-printing of living cells for regenerative medicineForthcoming · deadline 22 September 2027 · European Union (EU-wide) · €39,300,000
• Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medicationsForthcoming · deadline 13 April 2027 · European Union (EU-wide) · €38,000,000
• Virtual Human Twin (VHT) Models for Cancer ResearchOpen · deadline 15 September 2026 · European Union (EU-wide) · €35,000,000
• Validation of fluid-derived biomarkers for the prediction and prevention of brain disordersClosed · deadline 11 April 2024 · European Union (EU-wide) · €25,000,000
• Bio-printing of living cells for regenerative medicineClosed · deadline 11 April 2024 · European Union (EU-wide) · €25,000,000
• Personalised prevention of non-communicable diseases - addressing areas of unmet needs using multiple data sourcesClosed · deadline 11 April 2024 · European Union (EU-wide) · €50,000,000

Programmes

• Horizon Europe (HORIZON) 927 calls on record
• European Defence Fund (EDF) 69 calls on record
• Programme for the Environment and Climate Action (LIFE) 61 calls on record
• Digital Europe Programme (DIGITAL) 38 calls on record
• Euratom Research and Training Programme (EURATOM) 22 calls on record
• Connecting Europe Facility (CEF) 20 calls on record
• Citizens, Equality, Rights and Values Programme (CERV) 12 calls on record
• Erasmus+ (ERASMUS+) 8 calls on record
• Research Fund for Coal & Steel (RFCS) 7 calls on record
• European Social Fund + (ESF) 5 calls on record